Paracetamol Hikma 10 mg/ml Infusionslösung Tyskland - tysk - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

paracetamol hikma 10 mg/ml infusionslösung

hikma pharma gmbh (3220831) - paracetamol - infusionslösung - teil 1 - infusionslösung; paracetamol (01212) 10 milligramm

Idarubicin Hikma 1 mg/ml Injektionslösung Tyskland - tysk - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

idarubicin hikma 1 mg/ml injektionslösung

hikma pharma gmbh (3220831) - idarubicinhydrochlorid - injektionslösung - 1 mg/ml - teil 1 - injektionslösung; idarubicinhydrochlorid (25766) 1 milligramm

Bortezomib Hikma 3,5 mg Pulver zur Herstellung einer Injektionslösung Tyskland - tysk - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

bortezomib hikma 3,5 mg pulver zur herstellung einer injektionslösung

hikma pharma gmbh (3220831) - bortezomibanhydrid - pulver zur herstellung einer injektionslösung - teil 1 - pulver zur herstellung einer injektionslösung; bortezomibanhydrid (43230) 3,336 milligramm

AMLODIPINE BESYLATE tablet USA - engelsk - NLM (National Library of Medicine)

amlodipine besylate tablet

hikma pharmaceuticals usa inc. - amlodipine besylate (unii: 864v2q084h) (amlodipine - unii:1j444qc288) - amlodipine 2.5 mg - amlodipine besylate tablets are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including amlodipine besylate tablets. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a variety of pharmacologic

Cisatracúrio Hikma 2 mg/ml Solução injetável ou para perfusão Portugal - portugisisk - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

cisatracúrio hikma 2 mg/ml solução injetável ou para perfusão

hikma farmacêutica (portugal), s.a. - besilato de cisatracúrio - solução injetável ou para perfusão - 2 mg/ml - besilato de cisatracúrio 2.68 mg/ml - cisatracurium - genérico - duração do tratamento: curta ou média duração